Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is very misleading. Firstly, it was an addition in Q1. If you delve deeper, you will come across -
Vanguard Group Inc ownership in MULN / Mullen Automotive Inc
IMPORTANT: This company has reported a 25 to 1 reverse split as of 2023-05-04. The ownership data on this page IS NOT adjusted for this split. It is incumbent upon the reader to determine if this split affects this data and adjust the figures appropriately. Our engineering team is working on a solution to provide split-adjusted figures in the future.
The company has added 36,829,742 shares to its existing 45,673,616 in Q1, representing a 80% increase. With this move, Vanguard now reports holding a total of 82,503,358 shares in Mullen.
If you divide 82,503,358 by 25, then the true amount is 3,300,134 which you will see on the NASDAQ website.......https://www.nasdaq.com/market-activity/stocks/muln/institutional-holdings
Factories in southwestern China mak- ing components for Apple products and Toyota cars have been ordered to suspend production to save power during a record-breaking heatwave.
A representative of Foxconn, which produces iPads, Mac computers and smartwatches, said the impact at its plant in Chengdu, the capital of Sich- uan province, had been “limited”. Toy- ota said it was monitoring the situation and following government guidance.
Unprecedented heatwaves this sum- mer have prompted several Chinese provinces, including Zhejiang, Jiangsu and Anhui, to ration electricity use amid surging power demands to keep fans and air conditioning operating.
The extreme weather,with tempera- tures climbing past 40C, has piled fur- ther pressure on an economy that is already struggling under President Xi’s zero-Covid policy. Supply chains are under strain from the Ukraine war and military tensions around Taiwan.
Zeng Ming, a professor at North China Electric Power University, told local media China’s power demands had risen annually but this summer “large areas are experiencing sustained heatwaves, causing the peak load to rise too rapidly”.
In the eastern city of Hefei, chicken farmers have installed air conditioning after hens, stressed by the hot weather, stopped laying. Egg prices are said to have risen by up to 30 per cent.
Staff at the local animal husbandry and veterinary office said cows also produce less milk and sows have smaller litters in hot weather. They advised farmers to keep coops and pens cool and adjust feeding times. But egg production is 2 to 3 per cent lower even in air-conditioned coops, Global Times, a party-run newspaper, reported.
Several Chinese cities have reported
record high temperatures this summer. In Shanghai, the country’s financial hub, the temperature was above 40C for at least six days, the most sustained heatwave in 150 years.
After the eastern city of Hangzhou recorded 40.9C on August 11, the authorities deployed cloud-seeding air- craft to encourage rainfall.
Several local governments have called on factories to cut their power use and asked individuals to cope with higher room temperatures.
The power company in Dazhou announced yesterday it would increase the rolling power outage time for resi- dents to three hours, up from two and half hours, and called for unity in this summer’s battle not to overwhelm the grid.
Much of China’s power generation is still coal-fired, contributing to the country emitting 27 per cent of the world’s greenhouse gases in 2019.
The United States was the second- largest emitter, at 11 per cent, and India was third with 6.6 per cent of emissions, according to the US-based Rhodium Group.
China’s emissions more than trebled over the previous three decades, the think tank added. Beijing recently said it would suspend dialogue with the US on climate change, among other subjects, in reaction to the visit to Taiwan by Nancy Pelosi, Speaker of the House of Representatives.
The regime in Beijing has promised to achieve carbon neutrality by 2060 but refused to speed up progress, arguing that it must balance the goal with economic growth and that it must set its own pace.
Dong Xiucheng, an expert on carbon neutrality, told state media the extreme weather could become a new norm.
“Climate change needs high atten- tion from all countries,” Dong said. “The measure of all measures is to red
Where did you get this date from ?
Apple's Best Days Are Ahead: As iPhone Maker Nears $3T, Analyst Says His $200 Price Target Was 'Too Conservative'.
https://www.benzinga.com/analyst-ratings/analyst-color/21/12/24563646/apples-best-days-are-ahead-as-iphone-maker-nears-3t-analyst-says-his-200-price-targ
Seen at Apple 3.0 https://www.ped30.com/2021/12/12/apple-trading-strategies-12-13-21/
Michael Goldfeder said:
I’m thinking after the dip on Black Friday, this upward ride has been the reward for the long term shareholders of Apple who have held on tightly to their shares throughout the years of other assorted events. What is going to make this current uptrend different, is that an overhang in the stock with the flawed perception of the Epic case moving forward has now been removed. While “success is not illegal” was the lynchpin of that Federal Trial Court Decision, WS has been harping on the lone victory of sorts for Epic with the injunction granted by the Judge giving App Developers the right to contact consumers directly and bypass the Apple payment system. Having the rug pulled out from underneath Epic with a stay of that injunction, my impression is that a major overhang on Apple stock has just been removed by the Ninth Circuit Court of Appeals.
Moreover, as Robert Paul Leitao was gracious enough to share, an ancillary part of that Appellate decision which has received ZERO media attention, but will have major repercussions moving forward IMO, is that the Court more importantly denied an “Amicus Brief” (Friend of the Court) to be filed by the “Coalition for App Fairness.” These “Amicus Briefs” are routinely filed and granted acceptance by the Appellate Circuit Courts automatically on just about every case from what I’ve seen over the years in all Circuits and SCOTUS. When “this” Amicus Brief was denied by the Ninth Appellate Circuit Court, it was because they agreed with Apple that the “Coalition for App Fairness” was in actuality the alter ego of Epic Games and not a “Friend of the Court” brief. A ruling that IMO will have major implications for the “Coalition for App Fairness” in discussions with regulatory bodies in all places where Apple derives revenues moving forward.
In short, the Ninth Circuit Court of Appeals exposed this self anointed “Coalition for App Fairness” as basically a sham group cobbled together by Epic and several other major internet players (Blockchain.com; Matchgroup; Spotify; Tile; and others) as opportunists in this Epic Games v. Apple litigation money grab, with their concurrent agendas of making gobs of money on the iOS platform for free. While it still remains to be determined what the outcome of the rulings made by the trial judge as the finder of facts in the litigation will ultimately be after Appellate scrutiny, in reading her entire 187-page written and well crafted legally binding decision, along with the abuse of discretion standard that is involved by the Appellant Epic Games to overturn her ruling that Apple is not a monopoly, Apple is in a strong position from a legal standpoint to prevail on all 10 out of 10 issues. In addition, Epic already owes Apple more than $12 million in damages. A sum that will grow substantially with the attorneys fees that already have been generated, and will continue to grow throughout this Appellate journey that will go on for several years.
So while “Katy” and several other WS analysts came out this past week with new price targets on Apple based on AR Glasses in 2022, and the potential “Apple Car” in 2025, I truly believe that they have underestimated what might be an even bigger scenario with the Epic litigation story and how this Ninth Circuit Court of Appeals ruling exposing the “Coalition for App Fairness” as a money grab will assist Apple in the regulatory arena moving forward. That has me more excited than any potential and extraordinary innovations coming down the road from Apple.
Regardless of any release of AR glasses in 2022, the current revenues and demand, in conjunction with the chip shortages, will eventually come into equilibrium as consumers obtain the Apple products they desire. Long Apple!
Barron’s: Why $3 trillion will eventually look more like the floor than the ceiling.
https://www.ped30.com/2021/12/11/apple-barrons-3-trillion-floor/?utm_source=rss&utm_medium=rss&utm_campaign=apple-barrons-3-trillion-floor
If UiPath isn't giving you any love, then take a look at UI. Great for day trading, opens up, then closes down, great daily spread.
EV Makers Are Desperate To Ditch Cobalt.
https://oilprice.com/Energy/Crude-Oil/Battery-Metals-Boom-Might-Cancel-Cobalt.html
Orchid Island Capital Announces December 2021 Monthly Dividend, November 30, 2021 RMBS Portfolio Characteristics and Increase in Stock Repurchase Program.
https://www.nasdaq.com/press-release/orchid-island-capital-announces-december-2021-monthly-dividend-november-30-2021-rmbs
Q. When is a dividend worth more than its value?
A. When the stock is trading at a premium to its NAV (Net Asset Value), and you take your payment via a DRIP (Dividend Re Investment Plan.
e.g. You own 1000 shares of a $10.00 BDC and it pays a .10 dividend. So you are due a dividend of $1000.00 However, BDC's NAV is $8.00 which is what is used when the dividend is paid, so basically you receive 125 shares, which you can now sell for $10, and collect $1,250.00.
Indeed there are so many nuances to trading.
For example, PSEC gives a 5% discount - We have adopted a dividend reinvestment plan (also known as a “DRIP”) that provides for reinvestment of our distributions on behalf of our stockholders, unless a stockholder elects to receive cash. Effective May 21, 2020, we made a change to our long-standing DRIP started in 2004: stockholders may now receive a number of newly-issued shares based on 95% of the market price of our common stock (providing a 5% pricing discount), a benefit to shareholders enrolled in our DRIP (provided their brokers participate), as described in further detail in the 8-K filed April 17, 2020.
https://www.prospectstreet.com/investors/dividend-reinvestment-plan/default.aspx
CEF and BDC indexes available at
https://aicalliance.org/cef-indexes/diversified-indexes/
Dividend calendar is provided by NASDAQ -
https://www.nasdaq.com/market-activity/dividends
A chap hires an assassin to shoot his adulterous wife and her lover. The man and assassin are hidden in some hedges in the garden. The assassin is looking through the sights on his gun. He says “You still realize it's five thousand dollars per bullet don't you?”. The man replies “Yes that's fine. Go ahead. Shoot both"
The assassin asks, “Where do you want me to shoot them?”. The man replies “ Shoot my wife in the mouth. She was always giving me grief and shoot him in his balls for screwing my wife"
The assassin adjusts his sights. Takes another look and says “Hang on. Give it a minute and I might be able to save you a bullet."
Pilots on a commercial flight are chatting but forgot to turn the cabin speakers off.
“what I could use right now is a cup of coffee and a blow job.”
The stewardess hears and rushed up the isle to the cockpit. An observant passenger says to her as she hurries by, “you forgot the coffee.”
Five cannibals get appointed as programmers in an IT company.
During the welcoming ceremony the boss says:
"You're all part of our team now.
You can earn good money here, and you can go to the company canteen for something to eat.
So don't trouble the other employees".
The cannibals promise not to trouble the other employees.
Four weeks later the boss returns and says: "You're all working very hard, and I'm very satisfied with all of you.
One of our cleaners has disappeared however.
Do any of you know what happened to her?"
The cannibals disavow all knowledge of the missing cleaner.
After the boss has left, the leader of the cannibals says to the others:
"Which of you idiots ate the cleaner?"
One of the cannibals raises his hand hesitantly, to which the leader of the cannibals says:
"You FOOL! - For four weeks we've been eating team leaders, managers, and project managers and no-one has noticed anything, and now YOU have to go and eat the cleaner!"
CytoDyn Inc. (OTCMKTS:CYDY) Stock Sees Buying Interest On Value Buying.
https://topnewsguide.com/2021/09/13/cytodyn-inc-otcmktscydy-stock-sees-buying-interest-on-value-buying/
Seems like an outfit called The INVESTOR NEWSLETTER Daily is promoting CYDY.
Dear Investor,
Congratulations, you now have unrestricted access to the report, “The #1 Penny Stock Of 2021.”
Click This Link To Read Your Report Now.
Within this report you’ll discover which biotech stock is our #1 Penny Stock Pick of 2021. Have a look and see for yourself if this is a good fit for your portfolio! You can get in cheap and it has all the makings of a stock set to soar!
Click This Link To Read Your Report Now.
Sincerely,
The Investor Newsletter Daily Team
Look for Apple Stock To Rise at Least 30% to $188 With Its Powerful Free Cash Flow.
https://marketwirenews.com/news-releases/look-for-apple-stock-to-rise-at-least-30-to-188-with-5019205830229990.html
The future of Apple, will make $170 look like chump change.
https://www.yankodesign.com/2021/07/09/futuristic-apple-car-concepts-that-are-like-the-iphone-12-pro-max-of-smart-electric-vehicles/
Oil to hit $80 on largest ever demand jump – Goldman Sachs
https://www.rt.com/business/522424-oil-rally-goldman-sachs/
Rep. Jim Jordan (R-OH): “Are we gonna be here two years from now wearing masks …?”
— The Recount (@therecount) April 15, 2021
Dr. Fauci: “You’re ranting again.”
Rep. Jordan: “Here’s how it works, Dr. Fauci. I get to ask you the questions.” pic.twitter.com/7ufdQ65zG8
More than 80% of intubated COVID patients die in Brazil
https://medicalxpress.com/news/2021-03-intubated-covid-patients-die-brazil.html
I wonder if Mahboob will return the 200,000 shares he got ?
Friends of Leronlimab.
https://www.getleronlimab.com/support.aspx
https://www.sciencedirect.com/science/article/pii/S2589909021000174?dgcid=rss_sd_all
3. Case DESCRIPTION
The male subject was admitted to a London teaching hospital in the United Kingdom with confirmed nasopharyngeal swabs positive for SARS-CoV-2 infection by reverse transcriptase polymerase chain reaction (RT–PCR). He is of mixed race in his late 50’s with critical COVID-19. Other pertinent characteristics include a BMI of 37 kg/m2, prior smoker, and well-controlled hypertension. Following a positive test for SARS-CoV-2 infection, the subject was admitted to hospital with dyspnoea and pyrexia (Day 0). The subject received several investigational treatments prior to treatment with leronlimab. Upon admission, the subject was treated with dexamethasone for 10 days. Remdesivir was initiated on Day 1; a plasma exchange was administered on Day 4 for 10 days. Other drug interventions included intravenous antibiotics. The subject’s condition continued to deteriorate, and ECMO was initiated on Day 19. Four doses of leronlimab (700 mg), obtained from CytoDyn (CytoDyn inc. WA, USA) through an Emergency Investigational New Drug (EIND) application, were administered on Days 79, 86 and 93 and 100 post diagnosis. The subject responded extremely rapidly and was weaned off ECMO between Days 82 to 84, and he was discharged from the ECMO intensive care unit on Day 91. No adverse safety issues were identified with the administration of leronlimab in this subject. Oxygen therapy and intravenous antibiotics for ventilator-associated pneumonia were administered post weaning off ECMO. At last follow up the subject’s condition continues to improve and he is undergoing rehabilitation.
4. Discussion
Recent data suggest that severely dysregulated host immune responses to SAR-CoV-2, referred to as ‘cytokine storm’, may predominately mediate the morbidity and mortality of severe-to-critical COVID-19[13, 22, 23]. Cytokine storm primarily leads to lung inflammation causing acute respiratory distress syndrome (ARDS), but cytokine storm can also result in severe extrapulmonary manifestations, including thrombotic complications, myocardial dysfunction, and liver and kidney injury[24]. CCR5-expressing proinflammatory immune cells such as activated T-cells and macrophages are thought to play a key role in the cytokine storm response to COVID-19, suggesting that drug interventions that target the CCR5 system may represent a promising approach to treating COVID-19[13].
Leronlimab is a C-C chemokine receptor type 5 (CCR5)-specific humanised IgG4 monoclonal antibody. In a Phase 2, placebo-controlled, randomized clinical trial in subjects with mild-to-moderate COVID-19 leronlimab was shown to provide clinical benefit, primarily in subjects with more severe disease. A number of recent case series have demonstrated that treatment with leronlimab restores immune function and achieves clinical improvement in people with critical COVID-19. Taken together therapeutic interventions that target the chemokine receptor–ligand system may be an effective approach to treating COVID-19 because chemotaxis and trafficking of CCR5 expressing proinflammatory immune cells are thought to play an important role in this process. Importantly the long-term safety of leronlimab is already well established in the treatment of HIV[[17], [18], [19]].
This case is of particular interest because to the best of our knowledge this subject received ECMO for the longest period of any person in the United Kingdom with COVID-19 (66 days). He received his first dose of leronlimab on Days 79 after diagnosis and was successfully weaned off ECMO between Days 82 to 84 and discharged from the ECMO intensive care unit on Day 91. Considering the length of time this subject was on ECMO and the speed of the subject’s response to leronlimab we believe that this case adds critical insight to the growing body of evidence for leronlimab in treatment of critical COVID-19.
Perhaps you may want to read another letter written to Dr.Fauci
https://www.villagevoice.com/2020/05/28/an-open-letter-to-dr-anthony-fauci/
He does not know what he does not know. That was said by a former Chairman of Gilead, who also appeared to have no pharma knowledge.
At a February 12, 2002, news briefing, Secretary of Defense Donald Rumsfeld explained the limitations of intelligence reports: "There are known knowns. There are things we know we know. We also know there are known unknowns. That is to say, we know there are some things we do not know. But there are also unknown unknowns, the ones we don't know we don't know."
A mentor of mine imparted two pearls of wisdom which I have used for over 50 years -
1) Do not attempt to soft peddle the unpalatable.
2) Do not do business with a crook, you will get burned.
Good luck to us.
Or BP can do it for them. How Pfizer tried to bully Argentina and Brazil in exchange for vaccines.
https://www.wionews.com/world/how-pfizer-tried-to-bully-argentina-and-brazil-in-exchange-for-vaccines-366037
What is the source for those amounts ??
How is SNCGF related to MNXXF ??
What I found most informative, from the last 10Q,
On October 30, 2020, the Company signed a term sheet with Alpha Holdings, Inc (Alpha) whereby Alpha, subject to a definitive agreement agreeable to both parties will invest US $ 5,000,000 in the Company. The term sheet outlines the terms of the agreement with a projected closure by December 31, 2020 for an initial investment of $2,500,000 and an additional investment of $2,500,000 on about April 30, 2021. The investment will be in the Company’s common stock to be priced at a low of nine cents per share and a high of 10 cents per share subject to a 90 day weighted average pricing before closing. Upon completion of the $5,000,000 investment Alpha may elect a majority of the board of directors of the Company. The Company has determined that Alpha was treating this as an acquisition and not investment requiring control of the board of directors. the Company determined in the best interest of all shareholders to terminate it discussions with Alpha Holdings, Inc.
They moved on from CYDY, but got rebuffed by NBIO.
Meanwhile BLACK HART over on YMB said -
Verano trading at 28.50 times 290m shares equal 8.265b market cap. Sol has 9.3 percent which is 768.645m of current value. Divided by approx. 66m shares equates to 11.64/share plus 1.34 from Bluma value as per previous posts by calculations from Jtottham, is 12.98/share Cdn. Call other holdings and debt a wash and you can see how undervalued this is. Once the initial momentum from today is over this stock will return to closer to what it's value is actually calculated is. (just my opinion , but in the long run the numbers are usually right, or close to it !) GLTA
CAN $12.98 = US$10.22
https://seekingalpha.com/article/4395356-solcf-finding-value-in-weeds
That article mentioned an SOl price of $5.50, based on a VRNO IPO at US$10.00. However, VRNO is today currently trading around US$23.50, so perhaps we should be looking at $9.00 on SOLCF.
https://thedeepdive.ca/verano-holdings-to-commence-trading-this-morning/
Coming soon, another SOL investment being bought - BLUMA Wellness.
https://seekingalpha.com/article/4400961-bluma-wellness-built-in-profits-downside-protection-from-cresco-labs-acquisition
Chicago pot giants GTI, Verano quietly team up in joint venture
https://chicago.suntimes.com/cannabis/2021/2/9/22275233/marijuana-cannabis-illinois-dispensary-gti-verano-ildisp-nh-medicinal-dispensaries
OGI seems to be where the action is. Opened Monday @ $2.54, is now $7.00 after hours. Sold 55% and 58% of float Tue & Wed. Their sweet spot is the deal with Hyasynth, which had/has backing from Bill Gates. https://hyasynthbio.com